ASP2390

ASP2390 · Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP2390, covering 2025-10-27 to 2025-10-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust Mites [Phase 1]

See pricing